151 related articles for article (PubMed ID: 28591415)
1. Response-adapted therapy in Hodgkin lymphoma.
Broadfoot J; Johnson PWM
Hematol Oncol; 2017 Jun; 35 Suppl 1():33-36. PubMed ID: 28591415
[No Abstract] [Full Text] [Related]
2. Prognostic Biomarkers for Hodgkin Lymphoma.
Staege MS; Kewitz S; Bernig T; Kühnöl C; Mauz-Körholz C
Pediatr Hematol Oncol; 2015; 32(7):433-54. PubMed ID: 26380871
[TBL] [Abstract][Full Text] [Related]
3. Risk assessment in the management of newly diagnosed classical Hodgkin lymphoma.
Connors JM
Blood; 2015 Mar; 125(11):1693-702. PubMed ID: 25575542
[TBL] [Abstract][Full Text] [Related]
4. Introduction to a review series on Hodgkin lymphoma: change is here.
Sehn LH
Blood; 2018 Apr; 131(15):1629-1630. PubMed ID: 29500172
[No Abstract] [Full Text] [Related]
5. CD45 immunostaining in T-cell-rich B-cell lymphoma and lymphocyte predominance Hodgkin's disease.
Ashton-Key M; Isaacson PG
J Pathol; 1997 Apr; 181(4):462-3. PubMed ID: 9196447
[No Abstract] [Full Text] [Related]
6. A rare case of orbital hodgkin lymphoma demonstrating therapeutic response to a novel systemic medication.
Wajda BN; Rabinowitz MP
Orbit; 2017 Feb; 36(1):52-54. PubMed ID: 27824517
[TBL] [Abstract][Full Text] [Related]
7. Latent membrane protein 1 (LMP1) expression in Hodgkin lymphoma and its correlation with clinical and histologic parameters.
Hashmi AA; Hussain ZF; Hashmi KA; Zafar MI; Edhi MM; Faridi N; Khan M
World J Surg Oncol; 2017 Apr; 15(1):89. PubMed ID: 28427406
[TBL] [Abstract][Full Text] [Related]
8. Nodular sclerosing Hodgkin disease with primary manifestation in the orbit.
Gross ND; Wilson DJ; Dailey RA; Beckstead JH; Braziel RM
Ophthalmic Plast Reconstr Surg; 1998 May; 14(3):169-73. PubMed ID: 9612806
[TBL] [Abstract][Full Text] [Related]
9. A practical approach to the diagnosis of Hodgkin lymphoma.
Listinsky CM
Am J Clin Pathol; 2002 Jun; 117 Suppl():S76-94. PubMed ID: 14569804
[TBL] [Abstract][Full Text] [Related]
10. Novel Biomarker Approaches in Classic Hodgkin Lymphoma.
Aoki T; Steidl C
Cancer J; 2018; 24(5):206-214. PubMed ID: 30247255
[TBL] [Abstract][Full Text] [Related]
11. Metallothionein as a useful marker in Hodgkin lymphoma subclassification.
Penkowa M; Sørensen BL; Nielsen SL; Hansen PB
Leuk Lymphoma; 2009 Feb; 50(2):200-10. PubMed ID: 19199157
[TBL] [Abstract][Full Text] [Related]
12. Flowcytometric immunophenotyping in the diagnosis of pediatric lymphoma: how reliable is it and how can we optimize its use?
Sethuraman C; Simmerson M; Vora AJ; Cohen MC
J Pediatr Hematol Oncol; 2010 May; 32(4):298-303. PubMed ID: 20224437
[TBL] [Abstract][Full Text] [Related]
13. American Registry of Pathology Expert Opinions: Immunohistochemical evaluation of classic Hodgkin lymphoma.
O'Malley DP; Dogan A; Fedoriw Y; Medeiros LJ; Ok CY; Salama ME
Ann Diagn Pathol; 2019 Apr; 39():105-110. PubMed ID: 30802809
[TBL] [Abstract][Full Text] [Related]
14. Reed-Sternberg-Like Cells in Non-Hodgkin Lymphomas.
Gomez-Gelvez JC; Smith LB
Arch Pathol Lab Med; 2015 Oct; 139(10):1205-10. PubMed ID: 26414463
[TBL] [Abstract][Full Text] [Related]
15. Enhanced PD-L1 expression on tumor cells in primary cutaneous large T-cell lymphoma with CD30 expression as classic Hodgkin lymphoma mimics: A report of lymph node lesions of two cases.
Takahashi E; Tsuchida T; Baba S; Tsuzuki T; Shimauchi T; Tokura Y; Tamada Y; Nakamura S
Pathol Int; 2020 Oct; 70(10):804-811. PubMed ID: 32783303
[TBL] [Abstract][Full Text] [Related]
16. Options for first line therapy of Hodgkin lymphoma.
Longley J; Johnson PWM
Hematol Oncol; 2019 Jun; 37 Suppl 1(Suppl Suppl 1):82-86. PubMed ID: 31187527
[No Abstract] [Full Text] [Related]
17. CD137 is expressed in follicular dendritic cell tumors and in classical Hodgkin and T-cell lymphomas: diagnostic and therapeutic implications.
Anderson MW; Zhao S; Freud AG; Czerwinski DK; Kohrt H; Alizadeh AA; Houot R; Azambuja D; Biasoli I; Morais JC; Spector N; Molina-Kirsch HF; Warnke RA; Levy R; Natkunam Y
Am J Pathol; 2012 Sep; 181(3):795-803. PubMed ID: 22901750
[TBL] [Abstract][Full Text] [Related]
18. [Hodgkin lymphoma and non-Hodgkin lymphoma].
Yamaguchi M
Rinsho Ketsueki; 2013 Jan; 54(1):81-8. PubMed ID: 23391651
[No Abstract] [Full Text] [Related]
19. The role of PET/CT in the modern treatment of Hodgkin lymphoma.
Zaucha JM; Chauvie S; Zaucha R; Biggii A; Gallamini A
Cancer Treat Rev; 2019 Jul; 77():44-56. PubMed ID: 31260900
[TBL] [Abstract][Full Text] [Related]
20. Challenges and perspectives in the immunotherapy of Hodgkin lymphoma.
Michot JM; Lazarovici J; Ghez D; Danu A; Fermé C; Bigorgne A; Ribrag V; Marabelle A; Aspeslagh S
Eur J Cancer; 2017 Nov; 85():67-77. PubMed ID: 28892775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
